Market Cap:
$ SEC Filings
| Filing | Filed On |
|---|---|
| SCHEDULE 13G/A, AMENDMENT #2 | 14 Feb 2023 |
| SC 13G/A | 14 Feb 2023 |
| OYSTER POINT PHARMA, INC. | 14 Feb 2023 |
| 15-12G | 13 Jan 2023 |
| SC 13D/A | 13 Jan 2023 |
| 8-K/A | 13 Jan 2023 |
| NEW ENTERPRISE ASSOCIATES 14, L.P. -- OYSTER POINT PHARMA, INC. 13D/A(#2E) | 09 Jan 2023 |
| SC 13D/A | 05 Jan 2023 |
| EFFECT | 05 Jan 2023 |
| FORM 4 SUBMISSION | 05 Jan 2023 |
| FORM 4 SUBMISSION | 04 Jan 2023 |
| FORM 4 SUBMISSION | 04 Jan 2023 |
| FORM 4 SUBMISSION | 04 Jan 2023 |
| FORM 4 SUBMISSION | 04 Jan 2023 |
| FORM 4 SUBMISSION | 04 Jan 2023 |
| FORM 4 SUBMISSION | 04 Jan 2023 |
| FORM 4 SUBMISSION | 04 Jan 2023 |
| FORM 4 SUBMISSION | 04 Jan 2023 |
| FORM 4 SUBMISSION | 04 Jan 2023 |
| FORM 4 SUBMISSION | 04 Jan 2023 |
